Tag: Paul Kim
Simpson, Nishimura act on USD2.1bn Japan pharma buyout
Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin
Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin
IHCF vice president SongYi Son discusses the merits and possible obstacles for doing business in South Korea
Walter Chia, the chief representative officer for Asia-Pacific at INTA, elaborates on factors shaping IP across the region
Follow us on LinkedIn